The global cryoballoon ablation system market is estimated to be valued at US$ 1.1 billion in 2023 and is likely to surpass US$ 1.8 billion by 2033. The demand for cryoballoon ablation systems is projected to record a CAGR of 4.9% during the forecast period.
Key Market Highlights:
Hospitals and research institutes are the prominent end-use industries that have accelerated the cryoballoon ablation system market share.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Due to rising heart attacks, dementia, and death, the adoption of cryoballoon ablation systems is likely to increase worldwide to treat these diseases. However, a desire to lead a stress-free, healthy mental and social life also increases the demand for such products in the market. Using a cryoballoon ablation system can also reduce the duration and severity of the post-treatment traumatic pains after the treatment.
Manufacturing companies are also putting forth much effort in the segment where new technologies are being introduced. Furthermore, increasing the interest of investors and encouraging them to invest in this segment more actively also drives the cryoballoon ablation system market growth.
Continuous lesions around the ostium provided by the cryoballoon ablation system are also one of the key driving factors of the market.
The cryoballoon ablation system is gaining popularity, but the general public still needs to know its applications and benefits. As a result, the market needed to grow smoothly for an extended period before gaining the proper level of awareness to grow steadily. In addition to the lack of flexibility in the cryoballoon ablation system, the market is likely to encounter severe obstacles shortly. Conversely, cryoballoon ablation systems might also be limited in their growth by their rigidity, which can result in incomplete vein occlusion and inconsistent electrogram recording.
Researchers are constantly updating the technologies used in this system. However, it is a lengthy process that requires time and patience. Hence, continuous successful advancements are necessary for the market to remain the same.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 4.9% |
| Market Valuation (2023) | US$ 1.1 billion |
| Market Valuation (2033) | US$ 1.8 billion |
Principal Consultant
The global market secured a valuation of US$ 1.06 billion in 2022 with a CAGR of 3.8%. The demand for cryoballoon ablation systems is increasing due to cardiac patients and treatment procedures. Growing healthcare provider's awareness and adoption of advanced technologies playing a crucial role in improving patients' health are driving the global market.
Healthcare professionals increase the adoption of cryoballoon ablation systems for effective treatment with real-time monitoring integration. They are ensuring safe and efficient procedures compared to traditional ones to reduce risk and recover patients' health conditions.
Based on end-user type, the hospital segment dominates the market during the forecast period. Globally, the growing aging population and poor eating habits of young people have led to increased heart disease. Therefore, growth in surgeries increase the demand for cryoballoon ablation systems in hospitals. The hospital sector is anticipated to register a share of 48.1% in the global market by 2033.
Incorporating sophisticated infrastructure and advanced technologies into healthcare facilities has enhanced healthcare quality. By increasing patient inflow in the settings for ablation therapy, the network of hospitals across various countries increases accessibility to advanced treatments.
In both developing and developed countries, hospitals are expanding their networks to increase access to treatment. Consequently, hospitals aim to increase the availability of technology to help meet the needs of the enormous patient.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Countries | Forecast Share |
|---|---|
| United States | 34.4% |
| Germany | 9.0% |
| Japan | 4.6% |
| Countries | Forecast CAGR |
|---|---|
| Australia | 4.1% |
| China | 6.0% |
| India | 6.7% |
| United Kingdom | 3.6% |
The market is segmented geographically into North America, Europe, Latin America, Asia Pacific, the Middle East, and Africa. North America dominates the market by securing 41.2% of the share during the forecast period. Rising cardiac arrests and stroke deaths are the primary reason for the cryoballoon ablation system market growth. The United States is leading the market due to adopting unhealthy lifestyles and casual food habits, with a share of 34.4% by 2033.
Innovations in the healthcare sector are a prominent factor in growing the market continuously in North America. According to the Centers for Disease Control and Prevention, each year, America’s death rate crosses nearly 6.5 million from cardiovascular diseases. Moreover, the availability of advanced treatment options and raising awareness about cardiovascular diseases are likely to drive the market's growth.
A cryoablation catheter system designed to treat drug-refractory paroxysmal atrial fibrillation (A.F.) has been approved by the FDA in the United States. This technology provides a straightforward and efficient way to isolate pulmonary veins and allows patients to receive a minimally invasive, safe, and effective treatment for atrial fibrillation.
North America follows Europe to secure a higher share in the cryoballoon ablation system market by acquiring 28.7% of the claim during the forecast period. With rising, government initiatives and medical treatments have grown in the market in recent years. Moreover, technological advancement and research & development stimulate the demand for cryoballoon ablation systems.
At the Royal Papworth Hospital, a new generation of cryo balloons is being used to speed up treatment for patients with atrial fibrillation (A.F.). One million people in the United Kingdom suffer from A.F., which is treated through ablation. Moreover, it is expected that rising consumer preference for minimally invasive, effective, and painless surgical treatments are anticipated to drive the demand for cryoballoon ablation system in the future.
Healthcare facilities are increasingly adopting advanced technology-enabled devices along with sophisticated infrastructure, which positively impacts the success rate of medical procedures.
These critical cryoballoon ablation system providers are employing several strategies to improve sales and gain a competitive edge in the global cryoballoon ablation system market, including new product launches and approvals, partnerships, collaborations, acquisitions, mergers, etc. For instance,
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | United States, United Kingdom, Japan, India, China, Australia, Germany |
| Key Segments Covered | Region, End Use |
| Key Companies Profiled | Synmed.CO.UK; Pentax Medical; Medtronic; CPSI BIOTECH; Healthtronics, Inc.; Atricure, Inc.; Adagio Medical; Coopersurgical Inc.; SANARUS TECHNOLOGIES; Boston Scientific Corporation; BVM Medical Limited; Secure Medical; Galil Medical Inc.; Biosense Webster |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is valued at US$ 1.1 billion in 2023.
Pentax Medical, Medtronic, CPSI BIOTECH are key market players.
The market is forecast to register a CAGR of 4.9% through 2033.
The market will reach US$ 1.8 billion by 2033.
North America will dominate the market during the forecast period.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Users
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By End Users, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Users, 2023 to 2033
5.3.1. HospitalsTest
5.3.2. Hospitals
5.3.3. Clinics
5.3.4. Ambulatory Surgical Centers
5.4. Y-o-Y Growth Trend Analysis By End Users, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By End Users, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
6.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
6.3.1. North America
6.3.2. Latin America
6.3.3. Western Europe
6.3.4. Eastern Europe
6.3.5. South Asia and Pacific
6.3.6. East Asia
6.3.7. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
7.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
7.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
7.2.1. By Country
7.2.1.1. USA
7.2.1.2. Canada
7.2.2. By End Users
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By End Users
7.4. Key Takeaways
8. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By End Users
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By End Users
8.4. Key Takeaways
9. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. UK
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Rest of Western Europe
9.2.2. By End Users
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By End Users
9.4. Key Takeaways
10. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Poland
10.2.1.2. Russia
10.2.1.3. Czech Republic
10.2.1.4. Romania
10.2.1.5. Rest of Eastern Europe
10.2.2. By End Users
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By End Users
10.4. Key Takeaways
11. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. India
11.2.1.2. Bangladesh
11.2.1.3. Australia
11.2.1.4. New Zealand
11.2.1.5. Rest of South Asia and Pacific
11.2.2. By End Users
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By End Users
11.4. Key Takeaways
12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By End Users
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By End Users
12.4. Key Takeaways
13. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By End Users
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By End Users
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. USA
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By End Users
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By End Users
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By End Users
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By End Users
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By End Users
14.6. UK
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By End Users
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By End Users
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By End Users
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By End Users
14.10. Poland
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By End Users
14.11. Russia
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By End Users
14.12. Czech Republic
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By End Users
14.13. Romania
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By End Users
14.14. India
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By End Users
14.15. Bangladesh
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2022
14.15.2.1. By End Users
14.16. Australia
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2022
14.16.2.1. By End Users
14.17. New Zealand
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2022
14.17.2.1. By End Users
14.18. China
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2022
14.18.2.1. By End Users
14.19. Japan
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2022
14.19.2.1. By End Users
14.20. South Korea
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2022
14.20.2.1. By End Users
14.21. GCC Countries
14.21.1. Pricing Analysis
14.21.2. Market Share Analysis, 2022
14.21.2.1. By End Users
14.22. South Africa
14.22.1. Pricing Analysis
14.22.2. Market Share Analysis, 2022
14.22.2.1. By End Users
14.23. Israel
14.23.1. Pricing Analysis
14.23.2. Market Share Analysis, 2022
14.23.2.1. By End Users
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By End Users
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Synmed.CO.UK
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Pentax Medical
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Medtronic
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. CPSI BIOTECH
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Healthtronics, Inc.
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Atricure, Inc.
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Adagio Medical
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Coopersurgical Inc.
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. SANARUS TECHNOLOGIES
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. Boston Scientific Corporation
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Healthcare Insights
View Reports
Cryoballoon Ablation System Market
